Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alto Neuroscience (ANRO) Other Non Operating Income (2025)

Alto Neuroscience has reported Other Non Operating Income over the past 1 years, most recently at -$681000.0 for Q1 2025.

  • Quarterly results put Other Non Operating Income at -$681000.0 for Q1 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$681000.0 (changed N/A YoY), and the annual figure for FY2025 was -$681000.0, changed.
  • Other Non Operating Income reached -$681000.0 in Q1 2025 per ANRO's latest filing.
  • Across five years, Other Non Operating Income topped out at -$681000.0 in Q1 2025 and bottomed at -$681000.0 in Q1 2025.